Analytical Validation of a 29 Gene Scientific Pharmacogenetic Genotyping Panel
Validation of reference genes for expression evaluation in a murine trauma mannequin combining traumatic mind harm and femoral fracture
Systemic and native posttraumatic responses are sometimes monitored on mRNA expression stage utilizing quantitative real-time PCR (qRT-PCR), which requires normalisation to regulate for confounding sources of variability.
Normalisation requests reference (housekeeping) genes steady all through time and divergent experimental circumstances within the tissue of curiosity, that are essential for a dependable and reproducible gene expression evaluation.
Though earlier animal research analysed reference genes following remoted trauma, this multiple-trauma gene expression evaluation gives a notable examine analysing reference genes in primarily affected (i.e. bone/fracture callus and hypothalamus) and secondarily affected organs (i.e. white adipose tissue, liver, muscle and spleen), following experimental lengthy bone fracture and traumatic mind harm. We thought-about tissue-specific and generally used top-ranked reference candidates from totally different purposeful teams that had been evaluated making use of the established expression stability evaluation instruments NormFinder, GeNorm, BestKeeper and RefFinder.
In conclusion, reference gene expression in major organs is extremely time level in addition to tissue-specific, and subsequently requires cautious analysis for qRT-PCR evaluation. Moreover, the overall utility of Ppia, notably together with a second reference gene, is strongly beneficial for the evaluation of systemic results within the case of oblique trauma affecting secondary organs via native and systemic pathophysiological responses.

GCNF Antibody |
|||
| MBS9629079-02mL | MyBiosource | 0.2mL | 305 EUR |
GCNF Antibody |
|||
| MBS9629079-5x02mL | MyBiosource | 5x0.2mL | 1220 EUR |
GCNF Antibody |
|||
| MBS9435332-005mL | MyBiosource | 0.05mL | 325 EUR |
GCNF Antibody |
|||
| MBS9435332-01mL | MyBiosource | 0.1mL | 445 EUR |
GCNF Antibody |
|||
| MBS9435332-5x01mL | MyBiosource | 5x0.1mL | 1860 EUR |
anti- GCNF antibody |
|||
| FNab03390 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against GCNF |
|||
GCNF Conjugated Antibody |
|||
| C48479 | SAB | 100ul | 476.4 EUR |
GCNF Conjugated Antibody |
|||
| MBS9456445-01mLAF350 | MyBiosource | 0.1mL(AF350) | 480 EUR |
GCNF Conjugated Antibody |
|||
| MBS9456445-01mLAF405 | MyBiosource | 0.1mL(AF405) | 480 EUR |
GCNF Conjugated Antibody |
|||
| MBS9456445-01mLAF488 | MyBiosource | 0.1mL(AF488) | 480 EUR |
GCNF Conjugated Antibody |
|||
| MBS9456445-01mLAF555 | MyBiosource | 0.1mL(AF555) | 480 EUR |
GCNF Conjugated Antibody |
|||
| MBS9456445-01mLBiotin | MyBiosource | 0.1mL(Biotin) | 480 EUR |
Germ Cell Nuclear Factor (GCNF) Antibody |
|||
| abx131389-02mg | Abbexa | 0.2 mg | 337.5 EUR |
Germ Cell Nuclear Factor (GCNF) Antibody |
|||
| abx131389-05mg | Abbexa | 0.5 mg | 750 EUR |
Germ Cell Nuclear Factor (GCNF) Antibody |
|||
| abx131389-100g | Abbexa | 100 µg | 275 EUR |
Germ Cell Nuclear Factor (GCNF) Antibody |
|||
| 20-abx131389 | Abbexa |
|
|
Polyclonal NR6A1 / GCNF Antibody (Ligand-binding Domain) |
|||
| AMM06820G | Leading Biology | 0.05mg | 580.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NR6A1 / GCNF (Ligand-binding Domain). This antibody is tested and proven to work in the following applications: |
|||
GCNF |
|||
| E8EM1710-12 | EnoGene | 100ul | 275 EUR |
|
Description: Available in various conjugation types. |
|||
GCNF |
|||
| MBS8565176-01mL | MyBiosource | 0.1mL | 345 EUR |
GCNF |
|||
| MBS8565176-01mLAF405L | MyBiosource | 0.1mL(AF405L) | 565 EUR |
GCNF |
|||
| MBS8565176-01mLAF405S | MyBiosource | 0.1mL(AF405S) | 565 EUR |
GCNF |
|||
| MBS8565176-01mLAF610 | MyBiosource | 0.1mL(AF610) | 565 EUR |
GCNF |
|||
| MBS8565176-01mLAF635 | MyBiosource | 0.1mL(AF635) | 565 EUR |
GCNF (anti human nuclear recepter antibody, clone# H7921) |
|||
| PP-H7921-00 | Sceti | 0.1mg/100uL | 747.6 EUR |
|
Description: The GCNF (anti human nuclear recepter antibody, clone# H7921) is available in Europe and for worldwide shipping via Gentaur. |
|||
GCNF (NR6A1) Mouse Monoclonal Antibody [Clone:6F3] |
|||
| E45M19048 | EnoGene | 100 ug | 595 EUR |
GCNF (NR6A1) Mouse Monoclonal Antibody [Clone 6F3] |
|||
| E45M19048V-2 | EnoGene | 50 ul | 195 EUR |
Germ Cell Nuclear Factor (GCNF) Polyclonal Antibody |
|||
| CAU24184-100ul | Biomatik Corporation | 100ul | 235.2 EUR |
Germ Cell Nuclear Factor (GCNF) Polyclonal Antibody |
|||
| CAU24184-200ul | Biomatik Corporation | 200ul | 294 EUR |
Germ Cell Nuclear Factor (GCNF) Polyclonal Antibody |
|||
| MBS2032347-01mL | MyBiosource | 0.1mL | 175 EUR |
Germ Cell Nuclear Factor (GCNF) Polyclonal Antibody |
|||
| MBS2032347-02mL | MyBiosource | 0.2mL | 220 EUR |
Germ Cell Nuclear Factor (GCNF) Polyclonal Antibody |
|||
| MBS2032347-05mL | MyBiosource | 0.5mL | 355 EUR |
Germ Cell Nuclear Factor (GCNF) Polyclonal Antibody |
|||
| MBS2032347-1mL | MyBiosource | 1mL | 435 EUR |
Germ Cell Nuclear Factor (GCNF) Polyclonal Antibody |
|||
| MBS2032347-5mL | MyBiosource | 5mL | 1185 EUR |
Human Germ Cell Nuclear Factor (GCNF) Antibody Pair Kit (with Standard) |
|||
| MBS2101752-10x96Tests | MyBiosource | 10x96Tests | 1480 EUR |
Human Germ Cell Nuclear Factor (GCNF) Antibody Pair Kit (with Standard) |
|||
| MBS2101752-10x96TestsMBS2090685AbPairsSupportPack110x96Tests | MyBiosource | 10x96Tests+MBS2090685(AbPairsSupportPack1,10x96Tests) | 1600 EUR |
Human Germ Cell Nuclear Factor (GCNF) Antibody Pair Kit (with Standard) |
|||
| MBS2101752-5x96Tests | MyBiosource | 5x96Tests | 935 EUR |
Human Germ Cell Nuclear Factor (GCNF) Antibody Pair Kit (with Standard) |
|||
| MBS2101752-5x96TestsMBS2090685AbPairsSupportPack15x96Tests | MyBiosource | 5x96Tests+MBS2090685(AbPairsSupportPack1,5x96Tests) | 1010 EUR |
Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| PAC509Hu01 | Cloud-Clone | 100ul | 245 EUR |
Germ Cell Nuclear Factor (GCNF) Polyclonal Antibody (Human) |
|||
| 4-PAC509Hu01 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Germ Cell Nuclear Factor (GCNF) |
|||
GCNF Mouse mAb |
|||
| MBS8538939-01mL | MyBiosource | 0.1mL | 305 EUR |
GCNF Mouse mAb |
|||
| MBS8538939-01mLAF405L | MyBiosource | 0.1mL(AF405L) | 565 EUR |
GCNF Mouse mAb |
|||
| MBS8538939-01mLAF405S | MyBiosource | 0.1mL(AF405S) | 565 EUR |
GCNF Mouse mAb |
|||
| MBS8538939-01mLAF610 | MyBiosource | 0.1mL(AF610) | 565 EUR |
GCNF Mouse mAb |
|||
| MBS8538939-01mLAF635 | MyBiosource | 0.1mL(AF635) | 565 EUR |
NR6A1 / GCNF Rabbit Polyclonal (Ligand-binding Domain) Antibody |
|||
| TA317092 | Origene Technologies GmbH | 50 µg | Ask for price |
NR6A1 / GCNF Rabbit Polyclonal (Ligand-binding Domain) Antibody |
|||
| TA317093 | Origene Technologies GmbH | 50 µg | Ask for price |
Germ Cell Nuclear Factor (GCNF) Polyclonal Antibody (Human), PE |
|||
| 4-PAC509Hu01-PE | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Germ Cell Nuclear Factor (GCNF). This antibody is labeled with PE. |
|||
GCNF (NR6A1) (N-term) rabbit polyclonal antibody, Aff - Purified |
|||
| AP52935PU-N | Origene Technologies GmbH | 400 µl | Ask for price |
Germ Cell Nuclear Factor (GCNF) Polyclonal Antibody (Human), APC |
|||
| 4-PAC509Hu01-APC | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Germ Cell Nuclear Factor (GCNF). This antibody is labeled with APC. |
|||
Germ Cell Nuclear Factor (GCNF) Polyclonal Antibody (Human), Cy3 |
|||
| 4-PAC509Hu01-Cy3 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Germ Cell Nuclear Factor (GCNF). This antibody is labeled with Cy3. |
|||
Germ Cell Nuclear Factor (GCNF) Polyclonal Antibody (Human), HRP |
|||
| 4-PAC509Hu01-HRP | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Germ Cell Nuclear Factor (GCNF). This antibody is labeled with HRP. |
|||
Germ Cell Nuclear Factor (GCNF) Polyclonal Antibody (Human), FITC |
|||
| 4-PAC509Hu01-FITC | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Germ Cell Nuclear Factor (GCNF). This antibody is labeled with FITC. |
|||
Germ Cell Nuclear Factor (GCNF) Polyclonal Antibody (Human), Biotinylated |
|||
| 4-PAC509Hu01-Biotin | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Germ Cell Nuclear Factor (GCNF). This antibody is labeled with Biotin. |
|||
PE-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066290-01mL | MyBiosource | 0.1mL | 265 EUR |
PE-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066290-02mL | MyBiosource | 0.2mL | 355 EUR |
PE-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066290-05mL | MyBiosource | 0.5mL | 660 EUR |
PE-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066290-1mL | MyBiosource | 1mL | 810 EUR |
PE-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066290-5mL | MyBiosource | 5mL | 2330 EUR |
GCNF/RTR Mouse mAb |
|||
| E2220732 | EnoGene | 100ul | 225 EUR |
|
Description: Available in various conjugation types. |
|||
APC-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066291-01mL | MyBiosource | 0.1mL | 265 EUR |
APC-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066291-02mL | MyBiosource | 0.2mL | 355 EUR |
APC-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066291-05mL | MyBiosource | 0.5mL | 660 EUR |
APC-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066291-1mL | MyBiosource | 1mL | 810 EUR |
APC-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066291-5mL | MyBiosource | 5mL | 2330 EUR |
Cy3-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066292-01mL | MyBiosource | 0.1mL | 265 EUR |
Cy3-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066292-02mL | MyBiosource | 0.2mL | 355 EUR |
Cy3-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066292-05mL | MyBiosource | 0.5mL | 660 EUR |
Cy3-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066292-1mL | MyBiosource | 1mL | 810 EUR |
Cy3-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066292-5mL | MyBiosource | 5mL | 2330 EUR |
HRP-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066294-01mL | MyBiosource | 0.1mL | 205 EUR |
HRP-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066294-02mL | MyBiosource | 0.2mL | 255 EUR |
HRP-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066294-05mL | MyBiosource | 0.5mL | 450 EUR |
HRP-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066294-1mL | MyBiosource | 1mL | 545 EUR |
HRP-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066294-5mL | MyBiosource | 5mL | 1530 EUR |
Germ Cell Nuclear Factor (GCNF) Polyclonal Antibody (Human), APC-Cy7 |
|||
| 4-PAC509Hu01-APC-Cy7 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Germ Cell Nuclear Factor (GCNF). This antibody is labeled with APC-Cy7. |
|||
FITC-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066293-01mL | MyBiosource | 0.1mL | 215 EUR |
FITC-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066293-02mL | MyBiosource | 0.2mL | 265 EUR |
FITC-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066293-05mL | MyBiosource | 0.5mL | 480 EUR |
FITC-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066293-1mL | MyBiosource | 1mL | 585 EUR |
FITC-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066293-5mL | MyBiosource | 5mL | 1645 EUR |
GCNF ELISA KIT|Human |
|||
| EF009808 | Lifescience Market | 96 Tests | 826.8 EUR |
Biotin-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2094598-01mL | MyBiosource | 0.1mL | 185 EUR |
Biotin-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2094598-02mL | MyBiosource | 0.2mL | 230 EUR |
Biotin-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2094598-05mL | MyBiosource | 0.5mL | 385 EUR |
Biotin-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2094598-1mL | MyBiosource | 1mL | 470 EUR |
Biotin-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2094598-5mL | MyBiosource | 5mL | 1300 EUR |
APC/CY7-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066289-1mL | MyBiosource | 1mL | 1185 EUR |
APC/CY7-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066289-5mL | MyBiosource | 5mL | 3445 EUR |
APC/CY7-Linked Polyclonal Antibody to Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2066289-5x5mL | MyBiosource | 5x5mL | 15495 EUR |
Rabbit Polyclonal to Human NR6A1 / GCNF |
|||
| MBS244624-005mg | MyBiosource | 0.05mg | 615 EUR |
Rabbit Polyclonal to Human NR6A1 / GCNF |
|||
| MBS244624-5x005mg | MyBiosource | 5x0.05mg | 2605 EUR |
Rabbit Polyclonal to Human NR6A1 / GCNF |
|||
| MBS246731-005mg | MyBiosource | 0.05mg | 615 EUR |
Rabbit Polyclonal to Human NR6A1 / GCNF |
|||
| MBS246731-5x005mg | MyBiosource | 5x0.05mg | 2605 EUR |
GCNF (NR6A1) (NM_001489) Human Recombinant Protein |
|||
| E45H30304E1 | EnoGene | 50 ug | 527.58 EUR |
GCNF (NR6A1) (NM_001489) Human Recombinant Protein |
|||
| PH30304E1 | Leading Biology | 50 µg | Ask for price |
Recombinant Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2033238-001mg | MyBiosource | 0.01mg | 165 EUR |
Recombinant Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2033238-005mg | MyBiosource | 0.05mg | 290 EUR |
Recombinant Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2033238-01mg | MyBiosource | 0.1mg | 435 EUR |
Recombinant Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2033238-02mg | MyBiosource | 0.2mg | 525 EUR |
Recombinant Germ Cell Nuclear Factor (GCNF) |
|||
| MBS2033238-05mg | MyBiosource | 0.5mg | 1005 EUR |
Recombinant Germ Cell Nuclear Factor (GCNF) |
|||
| RPC509Hu01 | Cloud-Clone | 10ug | 164 EUR |
Recombinant Germ Cell Nuclear Factor (GCNF) |
|||
| 4-RPC509Hu01 | Cloud-Clone |
|
|
|
Description: Recombinant Human Germ Cell Nuclear Factor expressed in: E.coli |
|||
Recombinant Germ Cell Nuclear Factor (GCNF) |
|||
| RPU51805-100ug | Biomatik Corporation | 100ug | 504.9 EUR |
Recombinant Germ Cell Nuclear Factor (GCNF) |
|||
| RPU51805-1mg | Biomatik Corporation | 1mg | 2238.6 EUR |
Recombinant Germ Cell Nuclear Factor (GCNF) |
|||
| RPU51805-50ug | Biomatik Corporation | 50ug | 405.9 EUR |
Anti-GCNF antibody |
|||
| PAab03390 | Lifescience Market | 100 ug | 426 EUR |
Human Germ Cell Nuclear Factor (GCNF) Protein |
|||
| abx650014-100g | Abbexa | 100 µg | 212.5 EUR |
Human Germ Cell Nuclear Factor (GCNF) Protein |
|||
| 20-abx650014 | Abbexa |
|
|
Human Germ Cell Nuclear Factor (GCNF) Protein |
|||
| abx650014-200g | Abbexa | 200 µg | 375 EUR |
GCNF (NR6A1) (NM_001489) Human Over-expression Lysate |
|||
| E45H05740-2 | EnoGene | each | 395 EUR |
GCNF (NR6A1) (NM_001489) Human Over-expression Lysate |
|||
| LS002649 | BosterBio | 100ug | 628 EUR |
|
Description: Transient overexpression lysate of nuclear receptor subfamily 6, group A, member 1 (NR6A1), transcript variant 2 |
|||
Anti Bovine Leptin Antibody |
|||
| 111002 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Stercobilin Antibody Pab |
|||
| 165755 | Antibody Research Corporation | 100 µg | Ask for price |
Anti Plant Glycan Antibody [CCRC-M95] |
|||
| 401030 | Antibody Research Corporation | 100 µg | Ask for price |
Rapid Rat Antibody Isotyping Kit, 5pk |
|||
| 113103 | Antibody Research Corporation | 5 PKS | Ask for price |
Rapid Human Antibody Isotyping Kit, 5pk |
|||
| 113101 | Antibody Research Corporation | 5 PKS | Ask for price |
Rapid Mouse Antibody Isotyping Kit, 5pk |
|||
| 113102 | Antibody Research Corporation | 5 PKS | Ask for price |
Anti Mouse E3 Ubiquitin-Protein Ligase MYCBP2 Antibody, Phr1 |
|||
| 164056 | Antibody Research Corporation | 100 µg | Ask for price |
GCNF (Nuclear Receptor Subfamily 6 Group A Member 1, Germ Cell Nuclear Factor, GCNF, hGCNF, Retinoid Receptor-related Testis-specific Receptor, RTR, hRTR, NR6A1) |
|||
| MBS630577-01mL | MyBiosource | 0.1mL | 675 EUR |
GCNF (Nuclear Receptor Subfamily 6 Group A Member 1, Germ Cell Nuclear Factor, GCNF, hGCNF, Retinoid Receptor-related Testis-specific Receptor, RTR, hRTR, NR6A1) |
|||
| MBS630577-5x01mL | MyBiosource | 5x0.1mL | 2880 EUR |
Growth and Analytical Validation of a 29 Gene Scientific Pharmacogenetic Genotyping Panel: Multi-Ethnic Allele and Copy Quantity Variant Detection
To develop a novel pharmacogenetic genotyping panel, a multidisciplinary workforce evaluated out there proof and chosen 29 genes implicated in interindividual drug response variability, together with 130 sequence variants and extra copy quantity variants (CNVs). Of the 29 genes, 11 had pointers revealed by the Scientific Pharmacogenetics Implementation Consortium.
Focused genotyping and CNV interrogation had been completed by multiplex single-base extension utilizing the MassARRAY platform (Agena Biosciences) and multiplex ligation-dependent probe amplification (MRC Holland), respectively.
Analytical validation of the panel was completed by a strategic mixture of > 500 unbiased exams carried out on 170 distinctive reference materials DNA samples, which included sequence variant and CNV accuracy, reproducibility, and specimen (blood, saliva, and buccal swab) controls. Among the many accuracy controls had been 32 samples from the 1000 Genomes Challenge that had been chosen primarily based on their enrichment of sequence variants included within the pharmacogenetic panel (VarCover.org).
Coupled with publicly out there samples from the Genetic Testing Reference Supplies Coordination Program (GeT-RM), accuracy validation materials was out there for almost all (77%) of interrogated sequence variants (100% with common allele frequencies > 0.1%), in addition to extra structural alleles with distinctive copy quantity signatures (e.g., CYP2D6*5, *13, *36, *68; CYP2B6*29; and CYP2C19*36).
Accuracy and reproducibility for each genotyping and duplicate quantity had been > 99.9%, indicating that the optimized panel platforms had been exact and strong. Importantly, multi-ethnic allele frequencies of the interrogated variants point out that the overwhelming majority of the overall inhabitants carries at the very least one among these clinically related pharmacogenetic variants, supporting the implementation of this panel for pharmacogenetic analysis and/or scientific implementation packages.
Wonderful needle aspiration cytomorphology of papillary thyroid carcinoma with NTRK gene rearrangement from a case sequence with predominantly indeterminate cytology
Background: Neurotrophic tyrosine kinase receptor (NTRK) rearrangement has been reported in a subset of papillary thyroid carcinoma (PTC) circumstances. Little is thought in regards to the cytomorphologic options of NTRK-rearranged PTC.
Strategies: We report an institutional sequence of 13 advantageous needle aspiration (FNA) specimens of NTRK-rearranged PTC with a predominantly indeterminate cytology prognosis. NTRK3 or NTRK1 rearrangements had been detected on FNA or surgical specimens by next-generation sequencing.
Outcomes: The 13 sufferers had a median age of 18 years; 10 sufferers had been feminine and three sufferers had been male. In 10 (77%) circumstances, cytology was indeterminate, and histopathologic follow-up was predominantly the follicular variant of PTC (n = 8 [62%]), largely infiltrative subtype. Of 12 FNA specimens out there for assessment, a predominant loosely cohesive group sample was essentially the most generally encountered architectural sample (n = 5 [41%]), adopted by single cell (n = 3 [25%]), thick wire (n = 2 [17%]), and microfollicular sample (n = 2 [17%]). Background lymphocytic thyroiditis was noticed in 9 circumstances. On the mobile stage, the cytoplasm was average and granular, sometimes vacuolated. Traditional PTC nuclear options (eg, nuclear enlargement, elongation, grooves, and nuclear membrane irregularity) had been current however had been usually focal and refined. Chromatin was usually granular. Intranuclear pseudoinclusions had been absent or uncommon.
Conclusion: Our examine demonstrates that almost all circumstances of NTRK rearrangement lack basic PTC cytomorphologic traits. Loosely cohesive teams and single cells with granular, typically vacuolated cytoplasm and refined nuclear options are sometimes seen on FNA specimens. Recognizing these traits could also be useful to preoperatively immediate molecular testing, together with NTRK rearrangement evaluation.
SS-A (Ro) Antigen |
|||
| MBS318128-5x02mg | MyBiosource | 5x0.2mg | 6135 EUR |
Ro/SS-A Antigen |
|||
| MBS611481-2mL | MyBiosource | 2mL | 445 EUR |
Ro/SS-A Antigen |
|||
| MBS611481-5x2mL | MyBiosource | 5x2mL | 1850 EUR |
SS-A / Ro Antigen Antibody |
|||
| abx022699-2ml | Abbexa | 2 ml | 594 EUR |
SS-A / Ro Antigen Antibody |
|||
| abx022699-400l | Abbexa | 400 µl | Ask for price |
SS-A / Ro Antigen Antibody |
|||
| abx022699-80l | Abbexa | 80 µl | 575 EUR |
OPMA04224-200UG - SS-A (Ro) Antigen Protein |
|||
| OPMA04224-200UG | Aviva Systems Biology | 0.2MG | 1499 EUR |
SS-A Antigen |
|||
| E61A00301 | EnoGene | 1mg | 750 EUR |
SS-A Antigen |
|||
| MBS569398-1mg | MyBiosource | 1mg | 1705 EUR |
SS-A Antigen |
|||
| MBS569398-5x1mg | MyBiosource | 5x1mg | 7395 EUR |
SS-A Antigen |
|||
| MBS8506877-1mg | MyBiosource | 1mg | 830 EUR |
SS-A Antigen |
|||
| MBS8506877-5x1mg | MyBiosource | 5x1mg | 3595 EUR |
Ro/SS-A Antigen (SSA1, Sjogren Syndrome Antigen A1, 52kD Ribonucleoprotein Autoantigen SS-A/Ro, RO52, RNF81, Tripartite Motif Protein 21, TRIM21) |
|||
| MBS651596-1000Units | MyBiosource | 1000Units | 1730 EUR |
Ro/SS-A Antigen (SSA1, Sjogren Syndrome Antigen A1, 52kD Ribonucleoprotein Autoantigen SS-A/Ro, RO52, RNF81, Tripartite Motif Protein 21, TRIM21) |
|||
| MBS651596-5x1000Units | MyBiosource | 5x1000Units | 7555 EUR |
Ro/SS-A Antigen (SSA1, Sjogren Syndrome Antigen A1, 52kD Ribonucleoprotein Autoantigen SS-A/Ro, RO52, RNF81, Tripartite Motif Protein 21, TRIM21) |
|||
| MBS651597-02mg | MyBiosource | 0.2mg | 1395 EUR |
Ro/SS-A Antigen (SSA1, Sjogren Syndrome Antigen A1, 52kD Ribonucleoprotein Autoantigen SS-A/Ro, RO52, RNF81, Tripartite Motif Protein 21, TRIM21) |
|||
| MBS651597-5x02mg | MyBiosource | 5x0.2mg | 6060 EUR |
Ro-60/SS-A Antigen (60kD), Recombinant, Human (SSA1, Sjogren Syndrome Antigen A1, 52kD Ribonucleoprotein Autoantigen SS-A/Ro, RO52, RNF81, Tripartite Motif Protein 21, TRIM21) |
|||
| MBS635764-001mg | MyBiosource | 0.01mg | 375 EUR |
Ro-60/SS-A Antigen (60kD), Recombinant, Human (SSA1, Sjogren Syndrome Antigen A1, 52kD Ribonucleoprotein Autoantigen SS-A/Ro, RO52, RNF81, Tripartite Motif Protein 21, TRIM21) |
|||
| MBS635764-005mg | MyBiosource | 0.05mg | 525 EUR |
Ro-60/SS-A Antigen (60kD), Recombinant, Human (SSA1, Sjogren Syndrome Antigen A1, 52kD Ribonucleoprotein Autoantigen SS-A/Ro, RO52, RNF81, Tripartite Motif Protein 21, TRIM21) |
|||
| MBS635764-5x005mg | MyBiosource | 5x0.05mg | 2210 EUR |
Borrelia Afzelii Antigen |
|||
| NAT41583-100 | The Native Antigen Company | 0.1 | 395.28 EUR |
|
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
|||
Borrelia Afzelii Antigen |
|||
| NAT41583-500 | The Native Antigen Company | 0.5 | 1187.13 EUR |
|
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
|||
Borrelia Garinii Antigen |
|||
| NAT41584-100 | The Native Antigen Company | 0.1 | 395.28 EUR |
|
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
|||
Borrelia Garinii Antigen |
|||
| NAT41584-500 | The Native Antigen Company | 0.5 | 1187.13 EUR |
|
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
|||
Brucella Abortus Antigen |
|||
| NAT41599-100 | The Native Antigen Company | 0.1 | 395.28 EUR |
|
Description: Brucella abortus lysate, produced by fermentation. |
|||
Brucella Abortus Antigen |
|||
| NAT41599-500 | The Native Antigen Company | 0.5 | 1187.13 EUR |
|
Description: Brucella abortus lysate, produced by fermentation. |
|||
Candida Albicans Antigen |
|||
| NAT41601-100 | The Native Antigen Company | 0.1 | 395.28 EUR |
|
Description: Candida albicans is grown on solid medium, washed, disrupted and subjected to an extraction process. The antigen consists of cytoplasmic and cell wall components. |
|||
Candida Albicans Antigen |
|||
| NAT41601-500 | The Native Antigen Company | 0.5 | 1187.13 EUR |
|
Description: Candida albicans is grown on solid medium, washed, disrupted and subjected to an extraction process. The antigen consists of cytoplasmic and cell wall components. |
|||
Canine Parvovirus Antigen |
|||
| NAT41594-100 | The Native Antigen Company | 0.1 | 395.28 EUR |
|
Description: Canine Parvovirus, produced in CRFK cells. |
|||
Canine Coronavirus Antigen |
|||
| NAT41590-100 | The Native Antigen Company | 0.1 | 395.28 EUR |
|
Description: Canine Coronavirus produced in A-72 cells. |
|||
Feline Calicivirus Antigen |
|||
| NAT41595-100 | The Native Antigen Company | 0.1 | 395.28 EUR |
|
Description: Feline Calicivirus produced in FC 3TG cells. |
|||
Helicobacter Pylori Antigen |
|||
| NAT41603-100 | The Native Antigen Company | 0.1 | 395.28 EUR |
|
Description: Bacteria are cultured on solid medium, harvested, washed and solubilised. The antigen is partially purified by detergent extraction and centrifugation. |
|||
Helicobacter Pylori Antigen |
|||
| NAT41603-500 | The Native Antigen Company | 0.5 | 1187.13 EUR |
|
Description: Bacteria are cultured on solid medium, harvested, washed and solubilised. The antigen is partially purified by detergent extraction and centrifugation. |
|||
Campylobacter Jejuni Antigen |
|||
| NAT41600-100 | The Native Antigen Company | 0.1 | 395.28 EUR |
|
Description: Campylobacter jejuni is cultured on solid medium. This antigen is a partially purified detergent extract of the membrane fraction. The main component is an outer membrane protein, approximately 45 kDa in SDS-PAGE. |
|||
Campylobacter Jejuni Antigen |
|||
| NAT41600-500 | The Native Antigen Company | 0.5 | 1187.13 EUR |
|
Description: Campylobacter jejuni is cultured on solid medium. This antigen is a partially purified detergent extract of the membrane fraction. The main component is an outer membrane protein, approximately 45 kDa in SDS-PAGE. |
|||
Chlamydia Trachomatis Antigen |
|||
| CT022-1000 | The Native Antigen Company | 1.0 | 382.41 EUR |
|
Description: Chlamydia trachomatis antigens from clarified cell lysate. |
|||
Mycoplasma Pneumoniae Antigen |
|||
| MP901-1000 | The Native Antigen Company | 1.0 | 1019.75 EUR |
|
Description: Mycoplasma pneumoniae whole organisms that have been purified and detergent treated to enrich antigenic proteins and decrease background. |
|||
Mycoplasma Pneumoniae Antigen |
|||
| MP901-200 | The Native Antigen Company | 0.2 | 272.96 EUR |
|
Description: Mycoplasma pneumoniae whole organisms that have been purified and detergent treated to enrich antigenic proteins and decrease background. |
|||
Neisseria Gonorrhoeae Antigen |
|||
| NG01-1000 | The Native Antigen Company | 1.0 | 382.41 EUR |
|
Description: Homogenised lysate of pure bacteria. |
|||
Echovirus Antigen, Recombinant |
|||
| REC31776-100 | The Native Antigen Company | 0.1 | 279.4 EUR |
|
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus |
|||
Echovirus Antigen, Recombinant |
|||
| REC31776-500 | The Native Antigen Company | 0.5 | 1053.23 EUR |
|
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus |
|||
Trichomonas Vaginalis Antigen |
|||
| TV01-1000 | The Native Antigen Company | 1.0 | 424.9 EUR |
|
Description: Washed & lysed suspension of whole protozoa |
|||
Echinococcus Granulosus Antigen |
|||
| NAT41602-100 | The Native Antigen Company | 0.1 | 395.28 EUR |
|
Description: Echinococcus granulosus material is derived from bovine hydatid cyst as sterile filtered cyst fluid. |
|||
Echinococcus Granulosus Antigen |
|||
| NAT41602-500 | The Native Antigen Company | 0.5 | 1187.13 EUR |
|
Description: Echinococcus granulosus material is derived from bovine hydatid cyst as sterile filtered cyst fluid. |
|||
Enterovirus Antigen, Recombinant |
|||
| REC31772-100 | The Native Antigen Company | 0.1 | 279.4 EUR |
|
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus IgA, IgG and IgM ELISA. |
|||
Enterovirus Antigen, Recombinant |
|||
| REC31772-500 | The Native Antigen Company | 0.5 | 1053.23 EUR |
|
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus IgA, IgG and IgM ELISA. |
|||
Cytomegalovirus Purified Antigen |
|||
| CMV-HP-100 | The Native Antigen Company | 0.1 | 321.89 EUR |
|
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation. |
|||
Cytomegalovirus Purified Antigen |
|||
| CMV-HP-1000 | The Native Antigen Company | 1.0 | 2115.47 EUR |
|
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation. |
|||
Cytomegalovirus Purified Antigen |
|||
| CMV-HP-500 | The Native Antigen Company | 0.5 | 1291.43 EUR |
|
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation. |
|||
Astrovirus Antigen (Type 1) |
|||
| AS02-1000 | The Native Antigen Company | 1.0 | 1669.97 EUR |
|
Description: A concentrated source of Astrovirus particles and Astrovirus proteins from a lysate of host cells. |
|||
Astrovirus Antigen (Type 1) |
|||
| AS02-200 | The Native Antigen Company | 0.2 | 446.78 EUR |
|
Description: A concentrated source of Astrovirus particles and Astrovirus proteins from a lysate of host cells. |
|||
Yersinia pestis V antigen |
|||
| REC32028-100 | The Native Antigen Company | 0.1 | 326.34 EUR |
|
Description: Yersinia pestis V antigen (LcrV antigen, capsule protein fraction 1, type III secretion system needle tip protein). The protein is produced as an N-terminal GST fusion, with GST being cleaved by thrombin and is not present in the final product. |
|||
Yersinia pestis V antigen |
|||
| REC32028-500 | The Native Antigen Company | 0.5 | 1386.95 EUR |
|
Description: Yersinia pestis V antigen (LcrV antigen, capsule protein fraction 1, type III secretion system needle tip protein). The protein is produced as an N-terminal GST fusion, with GST being cleaved by thrombin and is not present in the final product. |
|||
Canine Herpes Virus Antigen |
|||
| NAT41592-100 | The Native Antigen Company | 0.1 | 395.28 EUR |
|
Description: Canine Herpes virus, produced in MDCK cells. |
|||
Canine Adenovirus 1 Antigen |
|||
| NAT41587-100 | The Native Antigen Company | 0.1 | 395.28 EUR |
|
Description: Canine Adenovirus Type 1, produced in A-72 cells. |
|||
Canine Adenovirus 2 Antigen |
|||
| NAT41588-100 | The Native Antigen Company | 0.1 | 395.28 EUR |
|
Description: Canine Adenovirus Type 2, produced in A-72 cells. |
|||
Toxoplasma gondii IgM antigen |
|||
| TG-IgM-100 | The Native Antigen Company | 0.1mg | 139.86 EUR |
|
Description: A highly purified source of Toxoplasma gondii membrane antigens, optimised for IgM detection. |
|||
Toxoplasma gondii IgM antigen |
|||
| TG-IgM-1000 | The Native Antigen Company | 1.0mg | 1189.51 EUR |
|
Description: A highly purified source of Toxoplasma gondii membrane antigens, optimised for IgM detection. |
|||
Canine Distemper Virus Antigen |
|||
| NAT41591-100 | The Native Antigen Company | 0.1 | 395.28 EUR |
|
Description: Canine Distemper virus, produced in SL-29 cells. |
|||
Norovirus GII.4 VP1 Antigen |
|||
| REC31620-100 | The Native Antigen Company | 0.1 | 305.15 EUR |
|
Description: Recombinant Norovirus GII.4 VP1 antigen produced in 293 human cells. |
|||
Norovirus GII.4 VP1 Antigen |
|||
| REC31620-1000 | The Native Antigen Company | 1.0 | 1847.65 EUR |
|
Description: Recombinant Norovirus GII.4 VP1 antigen produced in 293 human cells. |
|||
Norovirus GII.4 VP1 Antigen |
|||
| REC31620-500 | The Native Antigen Company | 0.5 | 1076.4 EUR |
|
Description: Recombinant Norovirus GII.4 VP1 antigen produced in 293 human cells. |
|||
Canine Parainfluenza Virus Antigen |
|||
| NAT41593-100 | The Native Antigen Company | 0.1 | 395.28 EUR |
|
Description: Canine Parainfluenza virus antigen, produced in MDCK cells. |
|||
Feline Panleukopenia Virus Antigen |
|||
| NAT41597-100 | The Native Antigen Company | 0.1 | 395.28 EUR |
|
Description: Feline Panleukopenia Virus (FPLV; feline parvovirus) antigen, produced in CRFK cells. |
|||
Cytomegalovirus Cell Lysate Antigen |
|||
| CMV-CL-100 | The Native Antigen Company | 0.1 | 225.32 EUR |
|
Description: A clarified cell lysate containing a mix of CMV antigens from all stages of the replication life cycle. |
|||
Cytomegalovirus Cell Lysate Antigen |
|||
| CMV-CL-1000 | The Native Antigen Company | 1.0 | 1435.63 EUR |
|
Description: A clarified cell lysate containing a mix of CMV antigens from all stages of the replication life cycle. |
|||
Feline Viral Rhinotracheitis Antigen |
|||
| NAT41598-100 | The Native Antigen Company | 0.1 | 395.28 EUR |
|
Description: Feline Viral Rhinotracheitis (FVR; feline herpes virus, FHV-1) antigen, produced in CRFK cells. |
|||
Herpes Simplex Virus 1 Antigen |
|||
| HS105-1000 | The Native Antigen Company | 1.0 | 1189.71 EUR |
|
Description: HSV-1 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
|||
Herpes Simplex Virus 1 Antigen |
|||
| HS105-200 | The Native Antigen Company | 0.2 | 297.43 EUR |
|
Description: HSV-1 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
|||
Herpes Simplex Virus 2 Antigen |
|||
| HS205-1000 | The Native Antigen Company | 1.0 | 1189.71 EUR |
|
Description: HSV-2 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
|||
Herpes Simplex Virus 2 Antigen |
|||
| HS205-200 | The Native Antigen Company | 0.2 | 297.43 EUR |
|
Description: HSV-2 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
|||
Ross River Virus Recombinant Antigen |
|||
| REC31969-100 | The Native Antigen Company | 0.1 | 764.81 EUR |
|
Description: Recombinant Ross River virus antigen expressed in HEK293 cells as virus-like particles and purified by sucrose density gradients and precipitation. Virus-like particles were then solubilized in PBS containing 0.2% SDS to prevent aggregation of particles. The preparation is not particulate. Antigens in the preparation include Envelope proteins 1 and 2 and Nucleoprotein. |
|||
Ross River Virus Recombinant Antigen |
|||
| REC31969-500 | The Native Antigen Company | 0.5 | 2871.26 EUR |
|
Description: Recombinant Ross River virus antigen expressed in HEK293 cells as virus-like particles and purified by sucrose density gradients and precipitation. Virus-like particles were then solubilized in PBS containing 0.2% SDS to prevent aggregation of particles. The preparation is not particulate. Antigens in the preparation include Envelope proteins 1 and 2 and Nucleoprotein. |
|||
Canine Adenovirus 1 and 2 Antigen |
|||
| NAT41589-100 | The Native Antigen Company | 0.1 | 395.28 EUR |
|
Description: A mixture of Canine Adenovirus Type 1 and Type 2, produced in A-72 cells. |
|||
Hepatitis B Virus E Antigen (HBeAg) |
|||
| REC31677-100 | The Native Antigen Company | 0.1 | 460.95 EUR |
|
Description: Recombinant Hepititis B Virus E Protein (HBeAg). |
|||
Hepatitis B Virus E Antigen (HBeAg) |
|||
| REC31677-500 | The Native Antigen Company | 0.5 | 1382.84 EUR |
|
Description: Recombinant Hepititis B Virus E Protein (HBeAg). |
|||
Hepatitis B Virus Core Antigen (HBcAg) |
|||
| REC31689-100 | The Native Antigen Company | 0.1 | 460.95 EUR |
|
Description: Recombinant Hepititis B Virus Core Protein (HBcAg). |
|||
Hepatitis B Virus Core Antigen (HBcAg) |
|||
| REC31689-500 | The Native Antigen Company | 0.5 | 1382.84 EUR |
|
Description: Recombinant Hepititis B Virus Core Protein (HBcAg). |
|||
Hepatitis C Virus Core Antigen (HCcAg) |
|||
| REC31693-100 | The Native Antigen Company | 0.1 | 489.27 EUR |
|
Description: Recombinant Hepatitis C Virus core protein is produced in E. coli and fused with a His-tag. |
|||
Hepatitis C Virus Core Antigen (HCcAg) |
|||
| REC31693-500 | The Native Antigen Company | 0.5 | 1469.11 EUR |
|
Description: Recombinant Hepatitis C Virus core protein is produced in E. coli and fused with a His-tag. |
|||
Feline Infectious Peritonitis Virus Antigen |
|||
| NAT41596-100 | The Native Antigen Company | 0.1 | 395.28 EUR |
|
Description: Feline Infectious Peritonitis virus (FIPV; feline coronavirus) antigen, produced in CRFK cells. |
|||
Herpes Simplex Virus 1 Lysate Antigen |
|||
| HS104-1000 | The Native Antigen Company | 1.0 | 272.96 EUR |
|
Description: A high concentration of HSV-1 particles and proteins from a clarified cell lysate. |
|||
Herpes Simplex Virus 2 Lysate Antigen |
|||
| HS204-1000 | The Native Antigen Company | 1.0 | 272.96 EUR |
|
Description: A high concentration of HSV-2 particles and proteins from a clarified cell lysate. |
|||
Toxoplasma gondii IgG antigen, RH strain |
|||
| TG-IgG-1000 | The Native Antigen Company | 1.0 mg | 338 EUR |
|
Description: A concentrated source of Toxoplasma gondii tachyzoite antigens, optimised for IgG detection, diluted to 0.5 mg/ml. |
|||
Toxoplasma gondii IgG antigen, RH strain |
|||
| TG-IgG-200 | The Native Antigen Company | 0.2 mg | 174.83 EUR |
|
Description: A concentrated source of Toxoplasma gondii tachyzoite antigens, optimised for IgG detection, diluted to 0.5 mg/ml. |
|||
Toxoplasma gondii IgG antigen, RH strain |
|||
| TG-IgG-5000 | The Native Antigen Company | 5.0 mg | 1436.48 EUR |
|
Description: A concentrated source of Toxoplasma gondii tachyzoite antigens, optimised for IgG detection, diluted to 0.5 mg/ml. |
|||
Legionella pneumophila antigen (native extract) |
|||
| NAT41580-100 | The Native Antigen Company | 0.1 | 395.28 EUR |
|
Description: Inactivated Legionella pneumophila antigen from culture. |
|||
Streptococcus Pneumoniae Antigen, Native Extract |
|||
| NAT41604-100 | The Native Antigen Company | 0.1 | 395.28 EUR |
|
Description: Inactivated Streptococcus pneumoniae antigen from culture. |
|||
Leptospira Biflexa Antigen (Strain Patoc 1) |
|||
| NAT41582-100 | The Native Antigen Company | 0.1 | 395.28 EUR |
|
Description: Inactivated Leptospira biflexa antigen (Strain Patoc 1) from broth culture. |
|||
Leptospira Biflexa Antigen (Strain Patoc 1) |
|||
| NAT41582-500 | The Native Antigen Company | 0.5 | 1187.13 EUR |
|
Description: Inactivated Leptospira biflexa antigen (Strain Patoc 1) from broth culture. |
|||
OPEF01636-1MG - Recombinant SS-A Antigen |
|||
| OPEF01636-1MG | Aviva Systems Biology | 1mg | 1683 EUR |
SS-B Antigen |
|||
| E61A00401 | EnoGene | 1mg | 750 EUR |
SS-B Antigen |
|||
| MBS569399-1mg | MyBiosource | 1mg | 1705 EUR |
SS-B Antigen |
|||
| MBS569399-5x1mg | MyBiosource | 5x1mg | 7395 EUR |
SS-B Antigen |
|||
| MBS8506643-1mg | MyBiosource | 1mg | 830 EUR |
SS-B Antigen |
|||
| MBS8506643-5x1mg | MyBiosource | 5x1mg | 3595 EUR |
Mouse Anti-Hepatitis B Surface Antigen Antibody (1834) |
|||
| MAB12230-100 | The Native Antigen Company | 0.1 | 278.11 EUR |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus surface antigen (1834). |
|||
Mouse Anti-Hepatitis B Surface Antigen Antibody (1837) |
|||
| MAB12231-100 | The Native Antigen Company | 0.1 | 278.11 EUR |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus surface antigen (1837) |
|||
Mouse Anti-Hepatitis B Surface Antigen Antibody (1838) |
|||
| MAB12232-100 | The Native Antigen Company | 0.1 | 278.11 EUR |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus surface antigen (1838) |
|||
Mouse Anti-Hepatitis B Virus E Antigen Antibody (1892) |
|||
| MAB12226-100 | The Native Antigen Company | 0.1 | 198.28 EUR |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (1892) |
|||
Mouse Anti-Hepatitis B Virus E Antigen Antibody (1893) |
|||
| MAB12227-100 | The Native Antigen Company | 0.1 | 278.11 EUR |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (1893) |
|||
Mouse Anti-Hepatitis B Virus E Antigen Antibody (1894) |
|||
| MAB12228-100 | The Native Antigen Company | 0.1 | 278.11 EUR |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (1894) |
|||
Mouse Anti-Hepatitis B Virus E Antigen Antibody (M132) |
|||
| MAB12298-100 | The Native Antigen Company | 0.1 | 279.4 EUR |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (M132) |
|||
Mouse Anti-Hepatitis B Virus E Antigen Antibody (M132) |
|||
| MAB12298-500 | The Native Antigen Company | 0.5 | 701.72 EUR |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (M132) |
|||
Mouse Anti-Hepatitis B Virus E Antigen Antibody (M133) |
|||
| MAB12299-100 | The Native Antigen Company | 0.1 | 279.4 EUR |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (M133) |
|||
Mouse Anti-Hepatitis B Virus E Antigen Antibody (M133) |
|||
| MAB12299-500 | The Native Antigen Company | 0.5 | 701.72 EUR |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (M133) |
|||
Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) |
|||
| MBS618195-02mg | MyBiosource | 0.2mg | 905 EUR |
Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) |
|||
| MBS618195-5x02mg | MyBiosource | 5x0.2mg | 3930 EUR |
Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) |
|||
| MBS616022-005mg | MyBiosource | 0.05mg | 620 EUR |
Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) |
|||
| MBS616022-02mg | MyBiosource | 0.2mg | 1050 EUR |
Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) |
|||
| MBS616022-5x02mg | MyBiosource | 5x0.2mg | 4580 EUR |
Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) |
|||
| MBS617008-01mL | MyBiosource | 0.1mL | 975 EUR |
Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) |
|||
| MBS617008-5x01mL | MyBiosource | 5x0.1mL | 4245 EUR |
Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) |
|||
| MBS621658-01mL | MyBiosource | 0.1mL | 600 EUR |
Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) |
|||
| MBS621658-5x01mL | MyBiosource | 5x0.1mL | 2555 EUR |
Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) |
|||
| MBS610413-01mL | MyBiosource | 0.1mL | 650 EUR |
Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) |
|||
| MBS610413-5x01mL | MyBiosource | 5x0.1mL | 2765 EUR |
Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) |
|||
| MBS600817-005mg | MyBiosource | 0.05mg | 700 EUR |
Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) |
|||
| MBS600817-02mg | MyBiosource | 0.2mg | 1120 EUR |
Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) |
|||
| MBS600817-5x02mg | MyBiosource | 5x0.2mg | 4900 EUR |
Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) |
|||
| MBS612544-01mL | MyBiosource | 0.1mL | 680 EUR |
Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) |
|||
| MBS612544-5x01mL | MyBiosource | 5x0.1mL | 2910 EUR |
Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) |
|||
| MBS615434-01mL | MyBiosource | 0.1mL | 645 EUR |
Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) |
|||
| MBS615434-5x01mL | MyBiosource | 5x0.1mL | 2760 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (FITC) |
|||
| MBS6150246-01mL | MyBiosource | 0.1(mL | 875 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (FITC) |
|||
| MBS6150246-5x01mL | MyBiosource | 5x0.1mL | 3800 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (PE) |
|||
| MBS6160852-01mL | MyBiosource | 0.1(mL | 875 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (PE) |
|||
| MBS6160852-5x01mL | MyBiosource | 5x0.1mL | 3800 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (AP) |
|||
| MBS6397325-01mL | MyBiosource | 0.1mL | 920 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (AP) |
|||
| MBS6397325-5x01mL | MyBiosource | 5x0.1mL | 3990 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) APC |
|||
| MBS6397326-01mL | MyBiosource | 0.1mL | 920 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) APC |
|||
| MBS6397326-5x01mL | MyBiosource | 5x0.1mL | 3990 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (Biotin) |
|||
| MBS6397327-01mL | MyBiosource | 0.1mL | 920 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (Biotin) |
|||
| MBS6397327-5x01mL | MyBiosource | 5x0.1mL | 3990 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (FITC) |
|||
| MBS6397328-01mL | MyBiosource | 0.1mL | 920 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (FITC) |
|||
| MBS6397328-5x01mL | MyBiosource | 5x0.1mL | 3990 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (HRP) |
|||
| MBS6397329-01mL | MyBiosource | 0.1mL | 920 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (HRP) |
|||
| MBS6397329-5x01mL | MyBiosource | 5x0.1mL | 3990 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (PE) |
|||
| MBS6397335-01mL | MyBiosource | 0.1mL | 920 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (PE) |
|||
| MBS6397335-5x01mL | MyBiosource | 5x0.1mL | 3990 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (AP) |
|||
| MBS6134337-01mL | MyBiosource | 0.1(mL | 875 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (AP) |
|||
| MBS6134337-5x01mL | MyBiosource | 5x0.1mL | 3800 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) APC |
|||
| MBS6139640-01mL | MyBiosource | 0.1(mL | 875 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) APC |
|||
| MBS6139640-5x01mL | MyBiosource | 5x0.1mL | 3800 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (Biotin) |
|||
| MBS6144943-01mL | MyBiosource | 0.1(mL | 875 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (Biotin) |
|||
| MBS6144943-5x01mL | MyBiosource | 5x0.1mL | 3800 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (HRP) |
|||
| MBS6155549-01mL | MyBiosource | 0.1(mL | 875 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (HRP) |
|||
| MBS6155549-5x01mL | MyBiosource | 5x0.1mL | 3800 EUR |
Plant Ss-A/Ro Antibody (Anti-SS-A/RO) ELISA Kit |
|||
| MBS9373696-INQUIRE | MyBiosource | INQUIRE | Ask for price |
SSA1 (Tripartite Motif-containing 21, 52kD Ribonucleoprotein Autoantigen Ro/SS-A, 52kD Ro Protein, RING Finger Protein 81, RNF81, Ro(SS-A), RO52, Sjoegren Syndrome Type A Antigen, SSA, SS-A, TRIM21, Tripartite Motif-containing Protein 21) |
|||
| MBS648085-01mg | MyBiosource | 0.1mg | 655 EUR |
SSA1 (Tripartite Motif-containing 21, 52kD Ribonucleoprotein Autoantigen Ro/SS-A, 52kD Ro Protein, RING Finger Protein 81, RNF81, Ro(SS-A), RO52, Sjoegren Syndrome Type A Antigen, SSA, SS-A, TRIM21, Tripartite Motif-containing Protein 21) |
|||
| MBS648085-5x01mg | MyBiosource | 5x0.1mg | 2800 EUR |
SSA1 (Tripartite Motif-containing 21, 52kD Ribonucleoprotein Autoantigen Ro/SS-A, 52kD Ro Protein, RING Finger Protein 81, RNF81, Ro(SS-A), RO52, Sjoegren Syndrome Type A Antigen, SSA, SS-A, TRIM21, Tripartite Motif-containing Protein 21) |
|||
| MBS623598-01mg | MyBiosource | 0.1mg | 875 EUR |
SSA1 (Tripartite Motif-containing 21, 52kD Ribonucleoprotein Autoantigen Ro/SS-A, 52kD Ro Protein, RING Finger Protein 81, RNF81, Ro(SS-A), RO52, Sjoegren Syndrome Type A Antigen, SSA, SS-A, TRIM21, Tripartite Motif-containing Protein 21) |
|||
| MBS623598-5x01mg | MyBiosource | 5x0.1mg | 3790 EUR |
SSA1 (Tripartite Motif-containing 21, 52kD Ribonucleoprotein Autoantigen Ro/SS-A, 52kD Ro Protein, RING Finger Protein 81, RNF81, Ro(SS-A), RO52, Sjoegren Syndrome Type A Antigen, SSA, SS-A, TRIM21, Tripartite Motif-containing Protein 21) |
|||
| MBS6010300-01mg | MyBiosource | 0.1(mg | 630 EUR |
SSA1 (Tripartite Motif-containing 21, 52kD Ribonucleoprotein Autoantigen Ro/SS-A, 52kD Ro Protein, RING Finger Protein 81, RNF81, Ro(SS-A), RO52, Sjoegren Syndrome Type A Antigen, SSA, SS-A, TRIM21, Tripartite Motif-containing Protein 21) |
|||
| MBS6010300-5x01mg | MyBiosource | 5x0.1mg | 2680 EUR |
SSA1 (Tripartite Motif-containing 21, 52kD Ribonucleoprotein Autoantigen Ro/SS-A, 52kD Ro Protein, RING Finger Protein 81, RNF81, Ro(SS-A), RO52, Sjoegren Syndrome Type A Antigen, SSA, SS-A, TRIM21, Tripartite Motif-containing Protein 21) |
|||
| MBS6002390-01mg | MyBiosource | 0.1(mg | 665 EUR |
SSA1 (Tripartite Motif-containing 21, 52kD Ribonucleoprotein Autoantigen Ro/SS-A, 52kD Ro Protein, RING Finger Protein 81, RNF81, Ro(SS-A), RO52, Sjoegren Syndrome Type A Antigen, SSA, SS-A, TRIM21, Tripartite Motif-containing Protein 21) |
|||
| MBS6002390-5x01mg | MyBiosource | 5x0.1mg | 2850 EUR |
SSA1 (Tripartite Motif-containing 21, 52kD Ribonucleoprotein Autoantigen Ro/SS-A, 52kD Ro Protein, RING Finger Protein 81, RNF81, Ro(SS-A), RO52, Sjoegren Syndrome Type A Antigen, SSA, SS-A, TRIM21, Tripartite Motif-containing Protein 21) |
|||
| MBS641293-005mg | MyBiosource | 0.05mg | 630 EUR |
SSA1 (Tripartite Motif-containing 21, 52kD Ribonucleoprotein Autoantigen Ro/SS-A, 52kD Ro Protein, RING Finger Protein 81, RNF81, Ro(SS-A), RO52, Sjoegren Syndrome Type A Antigen, SSA, SS-A, TRIM21, Tripartite Motif-containing Protein 21) |
|||
| MBS641293-5x005mg | MyBiosource | 5x0.05mg | 2680 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (MaxLight 405) |
|||
| MBS6193201-01mL | MyBiosource | 0.1(mL | 875 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (MaxLight 405) |
|||
| MBS6193201-5x01mL | MyBiosource | 5x0.1mL | 3800 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (MaxLight 550) |
|||
| MBS6214551-01mL | MyBiosource | 0.1(mL | 875 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (MaxLight 550) |
|||
| MBS6214551-5x01mL | MyBiosource | 5x0.1mL | 3800 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (MaxLight 750) |
|||
| MBS6235901-01mL | MyBiosource | 0.1(mL | 875 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (MaxLight 750) |
|||
| MBS6235901-5x01mL | MyBiosource | 5x0.1mL | 3800 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (MaxLight 650) |
|||
| MBS6225226-01mL | MyBiosource | 0.1(mL | 875 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (MaxLight 650) |
|||
| MBS6225226-5x01mL | MyBiosource | 5x0.1mL | 3800 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (MaxLight 490) |
|||
| MBS6203876-01mL | MyBiosource | 0.1(mL | 875 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (MaxLight 490) |
|||
| MBS6203876-5x01mL | MyBiosource | 5x0.1mL | 3800 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (MaxLight 405) |
|||
| MBS6397330-01mL | MyBiosource | 0.1mL | 920 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (MaxLight 405) |
|||
| MBS6397330-5x01mL | MyBiosource | 5x0.1mL | 3990 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (MaxLight 490) |
|||
| MBS6397331-01mL | MyBiosource | 0.1mL | 920 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (MaxLight 490) |
|||
| MBS6397331-5x01mL | MyBiosource | 5x0.1mL | 3990 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (MaxLight 550) |
|||
| MBS6397332-01mL | MyBiosource | 0.1mL | 920 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (MaxLight 550) |
|||
| MBS6397332-5x01mL | MyBiosource | 5x0.1mL | 3990 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (MaxLight 650) |
|||
| MBS6397333-01mL | MyBiosource | 0.1mL | 920 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (MaxLight 650) |
|||
| MBS6397333-5x01mL | MyBiosource | 5x0.1mL | 3990 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (MaxLight 750) |
|||
| MBS6397334-01mL | MyBiosource | 0.1mL | 920 EUR |
TROVE2 (RO60, SSA2, 60kD SS-A/Ro Ribonucleoprotein, Ro 60kD Autoantigen, Sjoegren Syndrome Antigen A2, Sjoegren Syndrome Type A Antigen, TROVE Domain Family Member 2) (MaxLight 750) |
|||
| MBS6397334-5x01mL | MyBiosource | 5x0.1mL | 3990 EUR |
TROVE2, CT (TROVE2, RO60, SSA2, 60kD SS-A/Ro ribonucleoprotein, Ro 60kD autoantigen, Sjoegren syndrome antigen A2, Sjoegren syndrome type A antigen, TROVE domain family member 2) |
|||
| MBS6010502-02mL | MyBiosource | 0.2(mL | 695 EUR |
TROVE2, CT (TROVE2, RO60, SSA2, 60kD SS-A/Ro ribonucleoprotein, Ro 60kD autoantigen, Sjoegren syndrome antigen A2, Sjoegren syndrome type A antigen, TROVE domain family member 2) |
|||
| MBS6010502-5x02mL | MyBiosource | 5x0.2mL | 2975 EUR |
Yersinia pestis chain B F1 capsule antigen, C-terminal His-tag |
|||
| REC32027-100 | The Native Antigen Company | 0.1 | 326.34 EUR |
|
Description: Yersinia pestis chain B F1 capsule antigen (Antig_Caf1) |
|||
Yersinia pestis chain B F1 capsule antigen, C-terminal His-tag |
|||
| REC32027-500 | The Native Antigen Company | 0.5 | 1386.95 EUR |
|
Description: Yersinia pestis chain B F1 capsule antigen (Antig_Caf1) |
|||
Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) (AP) |
|||
| MBS6466921-01mL | MyBiosource | 0.1mL | 1190 EUR |
Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) (AP) |
|||
| MBS6466921-5x01mL | MyBiosource | 5x0.1mL | 5195 EUR |
Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) (PE) |
|||
| MBS6466931-01mL | MyBiosource | 0.1mL | 1190 EUR |